Mylan Wants Supreme Court To Limit Patent Litigation Venue
Federal Circuit decision permits brand-name drug makers to file infringement suits against generic manufacturers in whatever jurisdiction they wish.
Federal Circuit decision permits brand-name drug makers to file infringement suits against generic manufacturers in whatever jurisdiction they wish.